LINCOLN PHARMACEUTICALS
Back to Balance Sheet
|
LINCOLN PHARMACEUTICALS Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | - | ₹1.07 Cr | ₹2.00 Cr | ₹2.04 Cr | ₹0.52 Cr |
What is the latest Total Debt ratio of LINCOLN PHARMACEUTICALS ?
| Year | Total Debt |
|---|---|
| Mar2025 | - |
| Mar2024 | ₹1.07 Cr |
| Mar2023 | ₹2.00 Cr |
| Mar2022 | ₹2.04 Cr |
| Mar2021 | ₹0.52 Cr |
How is Total Debt of LINCOLN PHARMACEUTICALS Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | - | -100.00 | |
| Mar2024 | ₹1.07 Cr | -46.57 | |
| Mar2023 | ₹2.00 Cr | -2.30 | |
| Mar2022 | ₹2.04 Cr | 293.08 | |
| Mar2021 | ₹0.52 Cr | - | |
Compare Total Debt of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,242.9 Cr | 17.5% | 29.6% | -8.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹407,827.0 Cr | -0.5% | 1.8% | -2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,363.0 Cr | -0.3% | -1.3% | 4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,193.0 Cr | 4.4% | 6% | 27.7% | Stock Analytics | |
| CIPLA | ₹109,519.0 Cr | 1% | -3% | -8.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,940.0 Cr | 1.1% | 8% | 3.8% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | 17.5% |
29.6% |
-8.9% |
| SENSEX | -0.9% |
-0.1% |
7% |
You may also like the below Video Courses